Contract Development & Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service (Contract Manufacturing {API Manufacturing, Finished Product [Solid Dosage Forms, Injectables, and Others], and Packaging}, and Contract Development {Formulation Development, Process Development & Scale-up, Analytical Method Development & Validation, Stability Testing, CMC & Regulatory Development Support, and Others}), By Molecule Type, By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Cardiology, Metabolic Disorders, and Others) and Regional Forecast, 2026-2034

Last Updated: July 20, 2026 | Format: PDF | Report ID: FBI102502

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 8.7% from 2026-2034
Unit	Value (USD Billion)
Segmentation	By Service, Molecule Type, Therapeutic Area, and Region
By Service	Contract Manufacturing API Manufacturing Finished Product Solid Dosage Forms Injectables Others Packaging Contract Development Formulation Development Process Development & Scale-up Analytical Method Development & Validation Stability Testing CMC & Regulatory Development Support Others
By Molecule Type	Small Molecules Biologics Cell & Gene Therapies Others
By Therapeutic Area	Oncology Infectious Diseases Neurology Cardiology Immunology & Inflammation Metabolic Disorders Others
By Region	North America (By Service, Molecule Type, Therapeutic Area, and Country) U.S. Canada Europe (By Service, Molecule Type, Therapeutic Area, and Country/Sub-region) Germany U.K. France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Service, Molecule Type, Therapeutic Area, and Country/Sub-region) China Japan India Australia & New Zealand Rest of Asia Pacific Rest of the World ( By Service, Molecule Type, Therapeutic Area, and Country/Sub-region)